Eli Lilly LLY
NYSE LLY
$1,445.40 +14.66 (+1.02%)
At close: Nov 13, 2026 · 4:00 PM EST

Eli Lilly (LLY) Cash & Current Investments (2009 - 2026)

Updated

Eli Lilly (LLY) reported Cash & Current Investments of $4.89 billion for Q3 2026, down 50.7% from $9.91 billion a year earlier and down 45.4% from the prior quarter.

Analysis

Eli Lilly (LLY) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Eli Lilly posted Cash & Current Investments of $7.27 billion, up 112.3% from FY2024.

  • Cash & Current Investments has increased for three consecutive years, with a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $3.42 billion in FY2024 (+16.9%), $2.93 billion in FY2023 (+32.4%), $2.21 billion in FY2022 (-43.4%) and $3.91 billion in FY2021 (+6.2%).
  • The Q3 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q2 2025.
  • Year over year, Cash & Current Investments gained in seven of the last eight quarters, with growth averaging 63.3%.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2025 (growth of 181.8%); the low point was Q3 2026 (a decline of 50.7%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $8.95 billion (Q2 2026), $5.28 billion (Q1 2026) and $7.27 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.23 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 10.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 505.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 14.27 Bn
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn 6.30 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.89 Bn
Jun 30, 2026 8.95 Bn
Mar 31, 2026 5.28 Bn
Dec 31, 2025 7.27 Bn
Sep 30, 2025 9.91 Bn
Jun 30, 2025 3.55 Bn
Mar 31, 2025 3.22 Bn
Dec 31, 2024 3.42 Bn
Sep 30, 2024 3.52 Bn
Jun 30, 2024 3.36 Bn
Mar 31, 2024 2.59 Bn
Dec 31, 2023 2.93 Bn
Sep 30, 2023 2.49 Bn
Jun 30, 2023 2.83 Bn
Mar 31, 2023 3.67 Bn
Dec 31, 2022 2.21 Bn
Sep 30, 2022 2.74 Bn
Jun 30, 2022 2.74 Bn
Mar 31, 2022 2.57 Bn
Dec 31, 2021 3.91 Bn
API Access

Eli Lilly Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LLY&period=max&api_key=YOUR_API_KEY